Q32 Bio Inc. (QTTB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 15M 30M 45M Q4 '18: 5.3M Q1 '19: 4.5M Q2 '19: 3.5M Q3 '19: 2.3M Q4 '19: 1.7M Q1 '20: 2M Q2 '20: 2.2M Q3 '20: 2.3M Q4 '20: 2.7M Q1 '21: 31.4M Q2 '21: 33M Q3 '21: 34.1M Q4 '21: 34M Q1 '22: 5.5M Q2 '22: 4.1M Q3 '22: 3.2M Q4 '22: 3.2M Q1 '23: 3.2M Q2 '23: 2.8M Q3 '23: 2M Q4 '23: 1.2M Q1 '24: 354K Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-150M -100M -50M 0 50M 100M 150M Q4 '17: -29.7M Q1 '18: -35.7M Q2 '18: -43M Q3 '18: -52M Q4 '18: -59.9M Q1 '19: -74.4M Q2 '19: -88.9M Q3 '19: -104.6M Q4 '19: -109.9M Q1 '20: -121.3M Q2 '20: -129M Q3 '20: -126M Q4 '20: -130.3M Q1 '21: -94.9M Q2 '21: -89.7M Q3 '21: -92.1M Q4 '21: -95.9M Q1 '22: -132.5M Q2 '22: -130.2M Q3 '22: -132.4M Q4 '22: -133.3M Q1 '23: -103M Q2 '23: -82M Q3 '23: -56.9M Q4 '23: -48.3M Q1 '24: -55.7M Q2 '24: -66.4M Q3 '24: -77.4M Q4 '24: -66.1M Q1 '25: -63.5M Q2 '25: -54.7M Q3 '25: -43.5M Q3 '18 Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25

Net Income TTM

-150M -100M -50M 0 50M 100M 150M Q4 '17: -30M Q1 '18: -34.7M Q2 '18: -41.1M Q3 '18: -48.7M Q4 '18: -55.6M Q1 '19: -69.2M Q2 '19: -83.1M Q3 '19: -98.5M Q4 '19: -103.9M Q1 '20: -115.4M Q2 '20: -124.5M Q3 '20: -123.1M Q4 '20: -128.7M Q1 '21: -94.4M Q2 '21: -89.6M Q3 '21: -92M Q4 '21: -95.8M Q1 '22: -2.6M Q2 '22: -1.2M Q3 '22: -4.3M Q4 '22: -5M Q1 '23: -103.9M Q2 '23: -80.7M Q3 '23: -61M Q4 '23: -53.7M Q1 '24: -45.9M Q2 '24: -57M Q3 '24: -60.6M Q4 '24: -47.7M Q1 '25: -59.8M Q2 '25: -52.3M Q3 '25: -42.1M Q4 '25: 29.8M Q1 '26: 33.2M Q2 '26: 33.8M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-120M -80M -40M 0 40M 80M 120M Q4 '18: -42.6M Q1 '19: -49.4M Q2 '19: -61.3M Q3 '19: -73.1M Q4 '19: -91.4M Q1 '20: -99.3M Q2 '20: -105.7M Q3 '20: -109.1M Q4 '20: -94.3M Q1 '21: -98.3M Q2 '21: -94.4M Q3 '21: -90.9M Q4 '21: -109.8M Q1 '22: -110.6M Q2 '22: -117.3M Q3 '22: -116.9M Q4 '22: -113.7M Q1 '23: -95.5M Q2 '23: -76M Q3 '23: -35.2M Q4 '23: -18.7M Q1 '24: -20.7M Q2 '24: -31.6M Q3 '24: -67M Q4 '24: -67.7M Q1 '25: -65.6M Q2 '25: -54.1M Q3 '25: -38.8M Q4 '25: -33.5M Q1 '26: -27.4M Q2 '26: -19.8M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Free Cash Flow TTM

-150M -100M -50M 0 50M 100M 150M Q4 '18: -67.5M Q1 '19: -83.8M Q2 '19: -98.5M Q3 '19: -107.1M Q4 '19: -113.2M Q1 '20: -112.7M Q2 '20: -113.7M Q3 '20: -115.6M Q4 '20: -98.1M Q1 '21: -100.8M Q2 '21: -97.1M Q3 '21: -93.9M Q4 '21: -112.1M Q1 '22: -113.3M Q2 '22: -119.4M Q3 '22: -118.5M Q4 '22: -114.9M Q1 '23: -95.6M Q2 '23: -76M Q3 '23: -35.2M Q4 '23: -18.7M Q1 '24: -20.7M Q2 '24: -31.6M Q3 '24: -67.1M Q4 '24: -67.8M Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '21: 50.4M Q2 '21: 56.5M Q3 '21: 57.1M Q1 '22: 57.9M Q2 '22: 57.4M Q3 '22: 57.4M Q1 '23: 344.6K Q2 '23: 347.9K Q3 '23: 346.3K Q1 '24: 2.3M Q2 '24: 12M Q3 '24: 12.1M Q1 '25: 12.2M Q2 '25: 12.2M Q3 '25: 12.2M Q1 '26: 14.1M Q2 '26: 20.3M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-180.00 -120.00 -60.00 0.00 60.00 120.00 180.00 Q4 '17: -12.85 Q1 '18: -14.15 Q2 '18: -11.88 Q3 '18: -9.48 Q4 '19: -2.47 Q1 '20: -2.61 Q2 '20: -2.78 Q3 '20: -2.73 Q4 '20: -2.79 Q1 '21: -2.03 Q2 '21: -1.79 Q3 '21: -1.71 Q4 '21: -1.69 Q1 '22: -0.08 Q2 '22: -0.05 Q3 '22: -0.10 Q4 '22: -0.09 Q1 '23: -21.52 Q2 '23: -37.70 Q3 '23: -77.63 Q4 '23: -154.20 Q1 '25: -4.76 Q2 '25: -4.12 Q3 '25: -3.26 Q4 '25: 2.43 Q1 '26: 2.79 Q2 '26: 3.13 Q2 '18 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.